Title of article
Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis
Author/Authors
Nobuo Wakata، نويسنده , , Toyokazu Saito، نويسنده , , Sachiko Tanaka، نويسنده , , Toshihiko Hirano، نويسنده , , Kitaro Oka، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2003
Pages
4
From page
5
To page
8
Abstract
Tacrolimus hydrate (FK506) reduces myasthenic symptoms due to its immunosuppressive properties. We studied the therapeutic effects of FK506 and noted improvement in 7 of 13 myasthenic patients on the clinical muscle test (myasthenia gravis, MG score). Two other patients with relapsing ocular symptoms improved. We also examined patient sensitivity to FK506, but could not predict such sensitivity before FK506 treatment in the present study.
Keywords
Myasthenia Gravis , Sensitivity test , Tacrolimus hydrate , Immunosuppressant
Journal title
Clinical Neurology and Neurosurgery
Serial Year
2003
Journal title
Clinical Neurology and Neurosurgery
Record number
464036
Link To Document